Marksans Pharma Ltd. Financials

15:59 May 30

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
261.42
+1.18 (+0.45%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Marksans Pharma Ltd. Financials

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
261.42
+1.18 (+0.45%)
15:59 May 30
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

50/100
Technically Neutral

Strength

6

Weakness

0

Opportunity

1

Threats

0

15.19 %

ROE %

11.70 %

ROA %

8.40

EPS

46.03

BVPS

14.40 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2025
Net Sales
1376.18 1490.84 1852.14 2177.41 2622.85
Operating Expenses +
1036.57 1231.95 1512.82 1718.83 2094.21
Raw Material
731.33 703.92 927.75 1111.98 1327.5
Increase Decrease in Cost
-136.28 12.9 -6.39 -73.86 -183.76
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
197.32 220.3 239.37 293.64 350.3
Miscellaneous Expenses
867.34 621.33 981.65 1275.63 600.17
Operating Profit
339.61 258.89 339.32 458.58 528.64
Other Income
6.69 41.85 59.31 50.42 70.38
Depreciation
36.15 44.78 51.85 74.27 83.38
Interest
7.99 8.45 9.13 11.2 11.66
Profit before tax and exceptio..
302.16 247.51 337.65 423.53 503.98
Exceptional Items
0 0 0 0 0
PBT
302.16 247.51 337.65 423.53 503.98
Provision for Taxation
63.63 60.7 72.33 108.63 121.35
Net Profit
238.54 186.81 265.32 314.9 382.63
NET Profit after MI
238.54 186.81 266.31 313.7 380.58
EPS
5.76 4.51 6.41 6.92 8.4
Operating Profit Margin (%)
24.68 17.37 18.32 21.06 20.16
Net Profit Margin (%)
17.33 12.53 14.38 14.41 14.51

Marksans Pharma Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 43.90 43.90 43.90 43.90 43.80
FII 22.20 22.00 21.30 18.60 15.60
MF 3.40 3.20 3.00 2.80 4.20
Public 29.40 29.90 30.70 33.80 35.40
Others 0.00 0.00 0.00 0.00 0.10
Others 1.10 1.00 1.10 0.90 0.90
Shareholder Shares Holding %
Download Our App On: